US study shows that EIS and Nevisense significantly improves clinicians’ diagnostic accuracy
STOCKHOLM, SWEDEN, — May 16, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a new study published in the US demonstrated that EIS and Nevisense can significantly improve clinical decisions in the dermatology day-to-day practice, especially for less experienced clinicians. The study titled – “Diagnostic Efficacy Of Electrical Impedance Spectroscopy Versus Dermoscopy For Pigmented Skin Lesions: A Pilot Study” and authored by Dr Jonathan Ungar, Associate Director and Assistant Professor,